Refine Results
- Applications and Industries
- Content Type
-
Content Type
- Analyzed With
- Chemical Group
- Language
-
Language
Applied Filters
To be enabled for e-commerce, you must first register.必威体育登录手机Agilent will then confirm your registration and inform you when your enablement is complete and you can begin transacting.
E-commerce is currently not available in your country.必威体育登录手机For select consumables and supplies you may now use Saved Cart link under your Account to build lists and send to your Agilent Representative.Simply login or register and you may begin.
必威体育登录手机Application note for the analysis of oxidized insulin chains using reversed phase Agilent ZORBAX RRHD 300SB-C18
- Publication Part Number: 5990-7988EN
- Created: 28 Apr 2011
- 325 KB
857750-902+
Publication Part Number | 5990-7988EN | |||
---|---|---|---|---|
Analysis | Analysed with Part No. |
|
||
Instrument |
|
|||
Analytical Technique | Technique |
|
||
Injection |
|
|||
Detection |
|
|||
Sample | Chemical Group |
|
||
Sample Matrix |
|
The number of proteins and antibodies in drug development and in clinical phase trials is growing rapidly.
- Publication Part Number: 5989-9899EN
- Created: 25 Nov 2008
- 110 KB
660750-902+660750-909+670750-902+
Publication Part Number | 5989-9899EN | |||||
---|---|---|---|---|---|---|
Analysis | Analysed with Part No. |
|
||||
Instrument |
|
|||||
Analytical Technique | Technique |
|
||||
Injection |
|
|||||
Detection |
|
|||||
Sample | Chemical Group |
|
||||
Sample Matrix |
|